title: Infections in biological agents used in rheumatic disease.
abstract: Immunosuppression and biological therapies are being used exponentially to treat inflammatory arthritis and connective tissue diseases. This article discusses the potential infectious complications of these therapies.
authors.affiliation: Rheumatology Department, University College, London Hospitals NHS Foundation Trust, London, UK. r.byng-maddick@ucl.ac.uk
authors.forename: Rachel
authors.initials: R
authors.lastname: Byng-Maddick
authors.forename: Michael
authors.initials: M
authors.lastname: Ehrenstein
mesh_terms: D001688:Biological Products / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007239:Infections / Q000139:chemically induced*; D012216:Rheumatic Diseases / Q000188:drug therapy*
chemical_list: D001688:Biological Products